Gilead earnings buoyed by Hepatitis-C drug
April 22, 2014 at 16:47 PM EDT
Sales of $1,000-a-pop Solvadi drug soar, helping earnings to triple
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.